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Abstract
Background: Genome-wide disease-gene finding approaches may sometimes provide us with a long list of
candidate genes. Since using pure experimental approaches to verify all candidates could be expensive, a number
of network-based methods have been developed to prioritize candidates. Such tools usually have a set of
parameters pre-trained using available network data. This means that re-training network-based tools may be
required when existing biological networks are updated or when networks from different sources are to be tried.
Results: We developed a parameter-free method, interconnectedness (ICN), to rank candidate genes by assessing
the closeness of them to known disease genes in a network. ICN was tested using 1,993 known disease-gene
associations and achieved a success rate of ~44% using a protein-protein interaction network under a test scenario
of simulated linkage analysis. This performance is comparable with those of other well-known methods and ICN
outperforms other methods when a candidate disease gene is not directly linked to known disease genes in a
network. Interestingly, we show that a combined scoring strategy could enable ICN to achieve an even better
performance (~50%) than other methods used alone.
Conclusions: ICN, a user-friendly method, can well complement other network-based methods in the context of
prioritizing candidate disease genes.
Background
The wide applications of high-throughput techniques
have enabled researchers to investigate disease mechan-
isms in a genome-wide scale [1,2]. However, one chal-
lenge is that these techniques are usually unable to
precisely pinpoint the causative genes. For example, a
linkage analysis may give a disease-linked chromosomal
region, which may harbor hundreds of candidate genes
[3,4]; an association study may identify a number of
false positives if the disease under investigation has a
complex inheritance pattern [5]. While a whole genome
re-sequencing can find a number of genetic variations in
a patient, only a few of them may play a role in the dis-
ease etiology [1]. Therefore, time-consuming and
laborious experiments are usually required to determine
the real disease genes from a large number of candidates
given by high-throughput experiments. One strategy to
accelerate the whole disease gene finding process is to
use a computational approach to prioritize candidate
genes.
Many computational approaches for prioritizing candi-
date genes have been developed, assuming that one dis-
ease could be caused by a group of functionally related
genes. Such approaches measure the functional similar-
ity of each candidate gene to known disease genes using
experimentally verified biological data (for details see
review [6-9] and Additional File 1). Among these
approaches, network-based ones have shown a good
performance. The working hypothesis of network-based
methods is that genes causing one disease are likely to
locate closely to each other in a biological network
[6,10]. Some network-based methods prioritize
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with known disease genes [11,12]; other methods further
consider the shortest-path distance between candidate
genes and known disease genes in a network when
direct links do not exist [13,14]. On the other hand, dif-
ferent methods might employ distinct scoring strategies.
Lage et al. [15] developed a Bayesian predictor that
could combine interactome and phenome to infer puta-
tive protein complexes likely to associate with a disease.
The CIPHER method scores the candidate genes using a
regression model of phenotype similarity and gene clo-
seness in a network [16]. Other network-based algo-
rithms, such as random walk [17], network flow [18],
page rank [19], network partition [20], and network
clustering [21], were also designed to prioritize candi-
date disease genes.
Network-based methods usually have some para-
meters that need to be trained using available data
sets. The random walk method needs a parameter to
control the probability of returning to the initial node
[17], and the network flow algorithm uses a parameter
to describe the relative importance of prior informa-
tion [18]. Lage’s method requires determining several
parameters in order to build the predictor [15]. When-
ever biological networks are updated or new training
data become available, their parameters should be re-
tuned in order to optimize their performance. It may
be difficult for biologists to rep eat these processes by
themselves. Additionally, a parameter set may just
work for certain cases. Here, we take the random walk
(RW) method as an example. Although a parameter
setting (r = 0.5) of RW appears to suffice the identifi-
cation of many disease genes, using other parameters
may be required to find certain disease genes (Figure
1). How to intelligently choose the parameters could
be a difficult task to users. We argue that a parameter-
free algorithm could be more useful to users in this
regard.
In this study, we propose a new candidate gene priori-
tization approach that measures the interconnectedness
(ICN) between genes in a network. It was designed to
be a parameter-free method. Unlike other network-
based methods, ICN measures closeness of each candi-
date genes to known disease genes by taking alternative
paths into consideration, in addition to the direct link
and the shortest-path distance. In comparison with
other outperforming network-based methods, ICN is a
competitive method. In particular, we show that an
impressive performance of prioritizing candidate disease
genes could be achieved by combining ICN with other
network-based methods. Finally, a novel type of spino-
cerebellar ataxia (SCA) was chosen to demonstrate the
ability of this method.
Results and discussion
Principles of the interconnectedness-based method
Most network-based gene prioritization methods,
including this one we have developed here, were created
on the basis that causative genes of one disease may
tend to locate closely in the network [6,10]. The
approaches taken by various methods differ on how clo-
seness between genes is measured. Before this method is
developed, other network-based methods prioritize can-
didate genes by finding direct-linked disease genes or
close disease genes using shortest-path distance. One
concern with these previous methods is that they might
be less effective than expected if there are noises or
missing direct links in the network used to measure
inter-gene closeness. Consequently, we designed the
InterConnectedNess-based method, ICN, to measure the
closeness between genes by considering alternative
paths, in addition to the shortest one, that could con-
nect candidate genes to known disease genes. Briefly,
ICN determines that these genes are more likely to
belong to the same functional module if two genes have
more shared interacting genes. A functional module
may correspond to a protein complex [15,18] or to a
signalling pathway [22]. If a functional module is impli-
cated with a disease, changes to a member gene in this
module may cause this disease [23,24]. We applied ICN
to the problem of prioritizing disease candidate genes.
Comparison with other network-based prioritization
algorithms
According to the comprehensive comparison performed
in [25], the best two outperforming methods for priori-
tizing candidate genes were the Random Walk method
(RW) [17] and the PRINCE (PRIoritizatioN and Com-
plex Elucidation) algorithm (PR) [18]. In this project,
they were re-implemented in order to compare their
Figure 1 Associations between parameter values and disease-
gene association predictions. There are 220 disease-gene
association cases in this example. The parameter r is used in
random walk method to control the probability of returning to
initial node [17]. The solid blocks indicate this method with a
specific parameter value successfully gives the true disease genes
the highest ranking (for details see the Materials and methods).
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optimized as described in [18] (for details see Materials
and Methods).
Two biological networks were recruited as the data
sets to evaluate the performance of ICN and other two
methods. These networks were chosen because each
network has features distinctive from that of the other.
We intended to examine if each method could perform
in a consistent manner using different types of network
data. The first one is a protein-protein interaction net-
work (PIN) consisting of 140,382 interactions and
12,164 genes. PIN consists of data retrieved from nine
protein-protein interaction data sources [26-34]. The
second one is a functional association network (FAN)
consisting of 1,217,908 interactions and 16,648 genes
downloaded from the STRING database [35]. These two
networks share 11,776 common genes and 95,630 com-
mon interactions. Two major differences between these
data sets are the number of interactions and the types
of edges. While PIN edges are un-weighted, FAN edges
are annotated with weights indicating the confidence of
functional linkage between each pair of connected genes
[36]. ICN is able to incorporate edge weights in quanti-
fying the closeness between genes in a network. The sta-
tistics of available data in each network is summarized
in Table 1.
A leave-one-out procedure was employed to carry out
the evaluation. The disease-gene associations were
obtained from OMIM [37]. These genes were manually
grouped in to different disease families as described in
Materials and Methods. In each validation trial, the
association of one test gene with a disease family was
removed, and each method was tried to re-build this
association. To mimic the situations we may encounter
when using different high-throughput genome-wide
techniques to find disease genes, we created two test
scenarios, the simulated linkage analysis and the whole
genome scan. In the simulated linkage analysis, each
time a test disease gene together with 100 genes on its
flanking regions was taken as the candidate set. In the
whole genome scan, each time a test disease gene
together with all human genes in the network, excluding
other members from the corresponding disease family,
was taken as the candidate set. If a test gene was ranked
top k in a candidate set in a trial, this trial was regarded
as a successful one. We further defined the “success
rate” as the fraction of successful trials for a method
under a particular test scenario.
The results of simulated linkage analysis for each
method are presented in Figure 2. 1,993 and 2,616 dis-
ease-gene associations were tested using PIN and FAN,
respectively. When PIN was used, ICN achieved the best
performance with a success rate of 44.7%, ranking the
known disease genes as top 1 candidate (k=1) in 870
out of 1,993 cases. RW and PR also achieved the similar
performance with a success rate of 43.3% (862/1993)
and 43.4% (865/1993), respectively. When the rank cut-
off (k) was increased, PR had the best performance,
while the performance of ICN was still comparable with
that of PR (Figure 2A). When FAN was used, RW
achieved a success rate of 71.3% (1865/2616), better
than that ICN (64.1%, 1678/2616) and PR (66.4%, 1738/
2616) did. On the other hand, as rank cutoff was
increased (k >= 5), the performance of ICN and PR was
better than that of RW (Figure 2B).
The performance comparison under the test scenario
of whole genome scan is shown in Figure 3. When PIN
was used, ICN successfully ranked the known disease
genes as top 1 candidate in 192 out of 1,993 cases, with
a success rate of 0.096. RW performance with a success
rate of 15.0% (299/1,993) was higher than ICN and PR
(6.9%, 137/1,993). Similarly, the performance of ICN
(10.4%, 272/2,616) was between RW (19.1%, 499/2,616)
and PR (6.7%, 174/2,616) when FAN was used. The
benchmark reveals that although ICN did not outper-
form in all cases, it was quite comparable to other
methods.
If the cases with disease genes being ranked as top 1
candidates by at least one of three prioritization meth-
ods were considered as successful predictions, the over-
all success rates so achieved were 54.3 % (1,083/1,993)
by using PIN and 79.2% (2,073/2,616) by using FAN,
Table 1 Statistics of biological networks
Protein-protein interaction network (PIN) Functional association network
(FAN)
Data source(s) Integration from DIP, BOND, IntAct, MINT, MIPS, HPRD, BioGRID, Reactome, and pathway
commons
STRING v8.2
Network type Unweighted Weighted
# genes 12,164 16,648
# interactions 140,382 1,217,908
# disease families 344 509
# disease-gene
associations
1,993 2,616
# disease genes 1,640 1,909
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analysis. The overall performance was much better than
that of respective methods. Figure 4 presents the over-
laps of successful predictions among ICN, RW, and PR.
No matter which biological network was used, RW and
PR shared more success cases than other combinations.
This is not really surprising, since RW and PR took a
similar iterative procedure to look for candidate genes
in a network [17,18]. Interestingly, each method pre-
dicted unique cases. In particular, ICN gave the highest
number of unique success cases using PIN, and it gave a
comparable number of unique cases with that of RW
using FAN. These results indicate that each method
may perform better than other methods on certain
cases. Analyzing the difference of the unique success
cases generated by different methods may help us get a
deeper understanding of unique advantage of each
method, which could assist us to further improve the
performance.
Exploring the cases uniquely predicted by respective
methods
Intuitively, topological properties of genes in a network
may affect the performance of candidate gene prioritiza-
tion when network-based methods are used. To under-
stand how the performance of different methods could
be influenced, we examined if the disease genes uniquely
identified by individual methods had distinctive topolo-
gical properties. For simplicity, disease genes uniquely
identified by ICN are denoted as ICN-unique genes/
cases, and so forth for other methods, in the following
text.
Firstly, the number of interacting partners, also
referred to as the degree in the graph theory [38], of
each method-unique case was considered. We noticed
that when PIN was used, the average degree of RW-
unique cases was significantly higher than these of ICN-
and PR-unique cases (P-value = 0.002 and 2.9×10-6,
Wilcoxon signed-rank test). Secondly, we explored to
which extent a method-unique gene may be located, in
a network, away from the known genes implicated in a
disease family. Here we found that when PIN was used,
the distribution of the shortest-path distances of ICN-
unique cases is similar to that of PR-unique cases (Fig-
ure 5B). Both ICN-unique and PR-unique cases are sig-
nificantly more distant from known disease genes than
that of RW-unique cases (P-values = 1.9×10-5 and
2.6×10-5, respectively, Wilcoxon signed-rank test). The
analysis of the method-unique cases using FAN yielded
a similar result (Additional File 2).
On the whole, these results support that a prioritiza-
tion method may outperform the others when candi-
date disease genes to be assessed have certain
method-favored topological properties. When candi-
date genes have more interacting partners in a net-
work and are closer to other known disease genes,
RW may perform better than the other methods. In
contrast, ICN and PR may outperform RW when
Figure 2 A performance of prioritization methods tested on simulated linkage analyses. The performance of different methods is assessed
by using PIN (A) and FAN (B), respectively.
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away from other known disease genes in a network.
Therefore, it is quite possible that combining the
ranking results of different methods may further
improve the performance of candidate gene prioritiza-
tion. In the next section, we show that a combined
scoring strategy did improve the performance of prior-
itizing candidate disease genes.
Figure 3 A performance of prioritization methods tested on whole genome scans. The performance of different methods is assessed by
using PIN (A) and FAN (B), respectively.
Figure 4 Venn diagram of successfully predicted cases among different prioritization methods. The cases which are successfully ranked
the known disease genes as top 1 candidate are compared among ICN, RW, and PR by using PIN (A) and FAN (B), respectively.
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strategy
Since each method may have its own favorite cases, we
tried to improve the performance of prioritization by
combining the results generated by different methods.
To preserve the unique advantage of each method, we
did not change any algorithmic approaches in them.
Instead, we used a combined scoring strategy by multi-
plying together the ranks generated by different methods
(for details see section Materials and Methods). The
performance of this new approach was also evaluated
using the leave-one-out procedure under a test scenario
of either simulated linkage analysis and whole-genome
scan.
Table 2 lists the performances of respective methods
and different combined scoring schemes tested in the
simulated linkage scenario. Here, we denote the scoring
scheme of combining the ranking results of ICN and PR
as the ICN-PR method, and so forth. Interestingly, all
combined scoring schemes achieved higher success rates
than respective methods. When PIN was used, the ICN-
PR method showed the best performance (success rate
48.9%). Besides, the ICN-RW method also showed a bet-
ter success rate (46.9%) than respective methods. On the
other hand, when FAN was used, the RW-PR method
outperformed the other individual and combined meth-
ods (success rate 73.7%). The ICN-PR method achieved
a success rate (72. 7%) close to the best one. All the
combined scoring schemes made substantial perfor-
mance improvement compared to respective methods
(ICN: 64.1%, RW: 71.3%, PR: 66.4%). Finally, when these
combined scoring schemes were tested in the whole
genome scan scenario, no performance improvement
could be found (data not shown). It is not surprising
s i n c ew ee x p e c tt h a tt h e r ec o u l db em i s s i n gp a r t si n
currently available biological networks and more genes
are yet to be identified to fill in the networks.
Here we further explored if the cases failed when
respective methods were used could be recovered using
the combined scoring schemes. The result is listed in
Table 3. When PIN was used, 11 and 25 cases (out of
911 cases failed using respective methods) could be
recovered by the ICN-RW and the ICN-PR methods,
respectively, but no cases could be recovered by the
RW-PR method or the ICN-RW-PR method. We also
tested if it could make a difference if FAN was used. It
turned out that the ICN-RW method and the ICN-PR
method rescued 27 and 22 cases (out of 543 cases failed
using respective methods), respectively. The RW-PR
method could rescue only one case, and the ICN-RW
-PR method did not really show a much better perfor-
mance (4 cases rescued).
Figure 5 Analysis of network topological properties on disease causing genes. The topological properties of disease genes in unique cases
which were successfully ranked the known disease genes as top 1 candidate by a specific method in PIN (Figure 3A) were compared in degree
(A) and average shortest-path distance between other disease-associated genes which are in the same disease family(B).
Table 2 Success rates of ranking known disease genes as
the best candidate
Success rate
(%)
ICN RW PR ICN-
RW
ICN-
PR
RW-
PR
ICN-RW-
PR
PIN 43.7 43.3 43.4 46.9 48.9 46.8 44.5
FAN 64.1 71.3 66.4 72.7 73.3 73.7 72.4
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based methods indeed enhances the performance of
prioritizing candidate disease genes. In particular, sub-
stantial performance improvement was made when
combining ICN with other methods.
Using ICN and combined scoring schemes to find
spinocerebellar ataxia genes
To demonstrate the ability of ICN and the combined
scoring schemes in finding novel disease genes, we pre-
sent a case study for spinocerebellar ataxia type 22
(SCA22) [39]. Autosomal dominant spinocerebellar atax-
ias (SCAs) are a group of progressive neurodegenerative
disorders characterized by the loss of balance and motor
coordination due to dysfunction of the cerebellum [40].
SCAs are genetically heterogeneous. To date, more than
30 genomic loci have been linked to different subtypes
of SCA; however, only 18 causative genes have been
determined [41,42]. Interestingly, these genes share
common interacting partners [43], suggesting that net-
work-based methods could be suitable for finding novel
SCA-causing genes. SCA22 has been found to link to
the locus on chromosome 1q21-23 [39], where 541 pro-
tein-coding genes were annotated (Ensembl release 58,
http://www.ensembl.org). Our aim was to prioritize
these 541 candidate disease genes.
The confirmed SCA-causing genes in Table 4 were
regarded as known disease genes for the SCA disease
family. There were 15 and 17 of them in PIN and FAN,
respectively. Table 5 and 6 present the top 10 candidate
genes (i.e. k = 10) prioritized using PIN and FAN,
respectively. Firstly, we tested individual methods. We
noticed that ICN, RW, and PR generated very different
results. No identical top one gene could be consistently
determined by different methods. In addition, when PIN
was used, only 2 genes, SPTA1 and GNAT2, were com-
monly identified by all methods (k = 10, Table 5). Simi-
larly when FAN was used, only 3 genes (KCNN3,
SPTA1, and KCNC4) commonly identified by all meth-
ods (k = 10, Table 6).
Secondly, we tested combined scoring schemes and
they appeared to generate more consistent results. When
PIN and FAN were used respectively, there were corre-
spondingly three (SPTA1, GNAT2, and NRAS) and
seven (KCNN3, SPTA1, CCT3, KCNC4, KCNA2,
KCND3, and KCNA3) common genes identified by all
combined scoring schemes (k = 10, Table 5 and 6).
Furthermore, SPTA1 and KCNN3 were consistently
picked out as the best candidates by all combined scoring
schemes using PIN and FAN, respectively. SPTA1 was
also ranked in the top 3 candidate genes by combined
scoring schemes when FAN was used. KCNN3 was not
included in the candidate list when PIN was used because
there was no interaction information for KCNN3.
From protein function and literature survey, we found
that SPTA1 and KCNN3 are very likely to associate
with SCA22. SPTA1 is a member of spectrin family,
functioning in actin crosslinking and as the molecular
scaffold proteins to determine cell shapes and to arrange
the transmembrane proteins. An in-frame deletion in
Table 3 Failed prediction cases recovered by combined
methods
# failed prediction cases
& # cases re-ranked as top 1 candidate
ICN-RW ICN-PR RW-PR ICN-RW-PR
PIN 911 11 25 0 0
FAN 543 27 22 1 4
& a failed prediction case indicates that no prioritization method can rank the
true disease gene as top 1 candidate.
Table 4 List of SCA-causing genes
SCA subtype Gene PIN
& FAN
&
SCA1 ATXN1 Y Y
SCA2 ATXN2 Y Y
SCA3 ATXN3 Y Y
SCA5 SPTBN2 Y Y
SCA6 CACNA1A Y Y
SCA7 ATXN7 Y Y
SCA8 ATXN8 N N
SCA10 ATXN10 Y Y
SCA11 TTBK2 Y Y
SCA12 PPP2R2B Y Y
SCA13 KCNC3 N Y
SCA14 PRKCG Y Y
SCA15 ITPR1 Y Y
SCA17 TBP Y Y
SCA27 FGF14 N Y
SCA28 AFG3L2 Y Y
SCA31 PLEKHG4 Y Y
DRPLA ATN1 Y Y
& whether the disease genes are in the given network. DRPLA: dentatorubral-
pallidoluysian atrophy
Table 5 Top 10 candidate genes for SCA22 by using PIN
Rank ICN RW PR ICN-RW ICN-PR RW-PR ICN-RW-
PR
1 SPTA1 NRAS YY1AP1 SPTA1 SPTA1 SPTA1 SPTA1
2 GNAT2 SPTA1 ECM1 GNAT2 YY1AP1 AHCYL1 GNAT2
3 TAF13 GNAT2 AHCYL1 NRAS GNAT2 NRAS NRAS
4 ISG20L2 GNAI3 FDPS ISG20L2 TAF13 ECM1 YY1AP1
5 FCGR2C AHCY1 SPTA1 FCGR2C ECM1 YY1AP1 ECM1
6 YY1AP1 STXBP3 STXBP3 TAF13 NRAS GNAT2 TAF13
7 PSMD4 ECM1 S100A7 PSMD4 STXBP3 STXBP3 STXBP3
8 NRAS CCT3 POLR3C GNAI3 PSMD4 GNAI3 AHCYL1
9 NGF RPS27 UBAP2L NGF POLR3C S100A7 GNAI3
10 NTRK1 S100A7 GNAT2 NTRK1 NGF FDPS PSMD4
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can cause SCA5 [44]. Recent studies have shown that
the mutant SPTBN2 disrupts fundamental intracellular
transport processes in synapses [45-47]. This is likely to
contribute to progressive neurodegenerative disease,
such as SCA. Therefore, SPTA1 may cause SCA22 in a
similar mechanism. Besides, KCNN3 is a member of the
gene family encoding the small conductance calcium-
activated potassium channels. A CAG repeat poly-
morphism has been annotated in the amino-terminal
coding region of KCNN3 [48]. Many studies revealed
that such repeat polymorphisms associate with psychia-
tric diseases, such as schizophrenia [49] and bipolar dis-
eases [50].
To further validate these two candidates experimen-
tally, an exome sequencing experiment was performed,
and several novel gene variations have been found on
SPTA1 in two SCA22 patients (Chung, M.-Y. et al.,
unpublished data). This preliminary result we present
here suggests that ICN and the combined scoring
schemes are able to identify the novel disease genes.
Conclusions
The InterConnectedNess-based method (ICN) is a bio-
logically intuitive and parameter-free approach for prior-
itizing candidate disease genes. There is no need for
users to train the parameters every time when biological
networks to be used are updated. ICN not only was
comparable to other well-known methods, such the ran-
d o mw a l km e t h o d( R W )a n dt h eP R I N C Ea l g o r i t h m
(PR), but also outperformed these methods when candi-
date disease genes are located more distantly to known
disease genes in a network. Furthermore, combined
ICN-RW or ICN-PR scoring schemes showed an
impressive performance improvement in prioritizing
candidate disease genes, suggesting that different net-
work-based methods may complement the weakness of
each other.
In this study, we created a very simple combined scor-
ing strategy by multiplying the ranks generated by
different methods. The success of this strategy implies
that there might still be a chance to further improve the
performance of network-based methods in prioritizing
candidate disease genes. To achieve this, we plan to try
other strategies. In addition to combining method-speci-
fic ranking results, combining network-specific ranking
results appears to be another promising strategy. In fact,
two algorithms, N-dimensional order statistics (NDOS)
[51] and discounted rating system (DRS) [52], have been
employed in some prioritization methods to combine
ranking results generated respectively by using different
network data sets. It would be interesting to find out if
the performances of ICN or other network-based meth-
ods can still be advanced when more heterogeneous
approaches are integrated together.
Materials and methods
Biological networks
Two kinds of biological networks were employed to
test the performance of network-based methods in this
study: protein-protein interaction network (PIN) and
functional association network (FAN). PIN was con-
structed by integrating protein-protein interaction data
from nine databases, including DIP [26], BIND [27],
IntAct [28], MIPS [29], MINT [30], HPRD [31], Bio-
GRID [32], Reactome [33], and Pathway Commons
[34]. Another dataset, FAN, was obtained from
STRING v8.2, which was a comprehensive gene asso-
ciation dataset containing directly physical interactions
and functional links from experimental evidence and
computational methods [35]. In both networks, the
identifier for each gene was mapped to Entrez Gene
ID, and self-interacting pairs were removed. Finally,
PIN consists with 140,382 interactions and 12,164
genes, and FAN consists of 1,217,908 interactions and
16,648 genes (Table 1). Each connection in FAN was
assigned a confidence scores from STRING, which
reflects the confidence of each gene-gene association.
P I Na n dF A Nw e r er e g a r d e da su n w e i g h t e da n d
weighted networks, respectively.
Table 6 Top 10 candidate genes for SCA22 by using FAN
Rank ICN RW PR ICN-RW ICN-PR RW-PR ICN-RW-PR
1 S100A6 SPTA1 KCNN3 KCNN3 KCNN3 KCNN3 KCNN3
2 KCNN3 CCT3 HCN3 SPTA1 S100A6 SPTA1 SPTA1
3 NGF KCNN3 SPTA1 S100A6 SPTA1 CCT3 S100A6
4 KCNA2 S100A11 PPM1J KCNA2 KCNC4 HCN3 CCT3
5 KCNC4 KCNA2 RHBG CCT3 PPM1J KCNC4 KCNC4
6 KCND3 KCNA3 KCNC4 KCNC4 KCNA2 KCNA2 KCNA2
7 KCNA3 KCND3 AHCYL1 KCND3 KCND3 S100A11 KCND3
8 SPTA1 KCNC4 CCT3 KCNA3 CCT3 PPM1J KCNA3
9 HIST2H2BE ARHGEF11 PYGO2 NGF KCNA3 KCNA3 PPM1J
10 SHC1 CD5L F11R F11R F11R KCND3 F11R
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The disease-gene associations were retrieved from the
Morbid Map in OMIM [37]. If the causative genes were
not included in the networks, their associations to dis-
eases were removed. Because the prioritizing methods
require related disease genes for prediction, the related
causative genes were manually grouped into a disease
family based on their given disorder name [53], and dis-
ease families that have only one causative gene were fil-
tered out. In total, 1,993 disease-gene associations
implicated with 344 disease families were recruited in
PIN and 2,616 disease-gene associations implicated with
509 disease families were recruited in FAN (Table 1).
Interconnectedness (ICN) between genes
The closeness between genes in a network was quanti-
fied by considering not only direct interaction of two
genes but also the number of connectors between genes.
As illustrated in Figure 6, the interconnectedness score
ICNi,j between two genes i and j was defined as:
ICN
kk
ij
ij iu ju
uN N
ij
ij
,
,, ,
()
=
∗+
∈∩ ∑ 2 ww w
(1)
where N is the neighboring genes of a given gene, and
u is the gene linked to both gene i and j. ω is a weight
of the connection between two genes, e.g. ωi,j corre-
sponds to the weight between gene i and j.I nF A N ,t h e
value of ω is within the interval between 0 and 1. In
PIN, however, ω is either 1 or 0, i.e. connected or
unconnected. Because the number of connectors may be
associated with the number of neighbors of each node,
the number of connectors between two genes is normal-
ized by the expected number of connectors between
these genes. ki is the sum of weights of gene i’sn e i g h -
boring connections and is defined as:
kii j
jN i
=
∈ ∑w , (2)
Figure 6 Illustration of interconnectedness between genes. This illustrates the interconnectedness (ICN) between gene i and j. Each node
represents a gene and each edge represents a either physical interaction or functional association. ω is the weight of each connection. u is the
set of connectors, which interact with both gene i and j.
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Page 9 of 12In an unweighted network, ki corresponds directly to
the degree, namely the number of neighbors of a given
gene [38].
Prioritizing candidate genes by interconnectedness scores
Candidate genes are then prioritized based on the ICN
scores calculated using equation 1. For a given disease
d, each candidate gene was scored by summing up the
closeness to the seed genes Sd, i.e. the genes in the same
disease family. The score of a given candidate gene i
was calculated as:
score
S
ICN i
d
ij
jS d
=
∈ ∑
1
||
, (3)
where ICNi,j is the connection score between gene i
and j. All candidate genes are then ranked based on
these scores.
Implement of random walk (RW) and PRINCE (PR)
methods
B o t ht h er a n d o mw a l k( R W )m e t h o d[ 1 7 ]a n dt h e
PRINE (PR) algorithm [18] apply an iterative procedure
to find candidate disease genes in a network. When the
difference between results of the previous and current
steps (measured by L1-norm) fell below 10
-10, the itera-
tion was halted, and candidate genes were ranked based
on the scores in the final step.
The precise behaviors employed by the two methods
to reach candidate genes in a network differ. RW [17]
simulates a random walker that starts from one or a set
of source nodes, and moves forward to neighboring
nodes with a probability proportional to the weight of
the connecting edge. RW also allows the walker to
move back to the source node with probability r in each
step. r controls how far the random walker could get
away from the source node. PR [18], a propagation-
based algorithm, exploits prior information on causative
genes for the same disease or similar ones and infers a
strength-of-association function to smooth over the net-
work (i.e. adjacent nodes are assigned similar values).
The parameter a in PR controls the relative importance
of prior information. Using the tuning procedure
described in [18], we set r =0 . 5a n da =0 . 9 ,w h i c h
make corresponding methods achieve the optimal per-
formance when the two network data sets described in
this study are used.
Experiment design and performance measurement
Two test scenarios were designed to evaluate the perfor-
mance of all methods: simulated linkage analyses and
whole genome scan. In the simulated linkage analysis, a
total of 100 genes flanking a test disease gene were
taken as the candidate genes. In the whole genome scan,
a test disease gene and all the genes in a biological net-
work excluding other members from the corresponding
disease gene family constitute the candidate gene list.
A leave-one-out procedure is used to assess the per-
formance of the different methods. In each trial, a dis-
ease-gene association was removed and remaining genes
in the same disease family were taken as seed genes to
reconstruct the association. We used the “success rate”
to represent the performance of a method. If the
removed disease-gene association was ranked in top k of
a candidate gene list, this trial was regarded as a suc-
cessful prediction. The “success rate” of a method is
defined as the fraction of successful predictions in all
cases tested given a particular combination of a network
data set and a test scenario.
Combing the prioritization results given by different
methods
For each candidate gene i,ac o m b i n e ds c o r eCSi was
calculated as:
CS R ii j
j
n
=
= ∏ ,
1
(4)
where Ri,j indicates the rank of gene i in method j.
The candidate genes were re-ranked using the combined
scores in an ascending order, i.e. the lower combined
score, the higher priority.
Additional material
Additional file 1: List of related algorithms and tools for prioritizing
disease candidate genes
Additional file 2: Analysis of network topological properties on
disease causing genes The topological properties of disease genes in
unique cases which were successfully ranked the known disease genes
as top 1 candidate by a specific method in FAN (Figure 3B) were
compared in degree (A) and average shortest-path distance between
other disease-associated genes which are in the same disease family(B).
List of abbreviations used
FAN: functional association network; ICN: interconnectedness; OMIM: Online
Mendelian Inheritance in Man; RW: random work method; PIN: protein-
protein interaction network; PR: PRINCE algorithm.
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